These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25239141)

  • 1. Cholesterol esters (CE) derived from hepatic sterol O-acyltransferase 2 (SOAT2) are associated with more atherosclerosis than CE from intestinal SOAT2.
    Zhang J; Sawyer JK; Marshall SM; Kelley KL; Davis MA; Wilson MD; Brown JM; Rudel LL
    Circ Res; 2014 Oct; 115(10):826-33. PubMed ID: 25239141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma cholesteryl esters provided by lecithin:cholesterol acyltransferase and acyl-coenzyme a:cholesterol acyltransferase 2 have opposite atherosclerotic potential.
    Lee RG; Kelley KL; Sawyer JK; Farese RV; Parks JS; Rudel LL
    Circ Res; 2004 Nov; 95(10):998-1004. PubMed ID: 15486318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New pyripyropene A derivatives, highly SOAT2-selective inhibitors, improve hypercholesterolemia and atherosclerosis in atherogenic mouse models.
    Ohshiro T; Ohtawa M; Nagamitsu T; Matsuda D; Yagyu H; Davis MA; Rudel LL; Ishibashi S; Tomoda H
    J Pharmacol Exp Ther; 2015 Nov; 355(2):299-307. PubMed ID: 26338984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-specific knockouts of ACAT2 reveal that intestinal depletion is sufficient to prevent diet-induced cholesterol accumulation in the liver and blood.
    Zhang J; Kelley KL; Marshall SM; Davis MA; Wilson MD; Sawyer JK; Farese RV; Brown JM; Rudel LL
    J Lipid Res; 2012 Jun; 53(6):1144-52. PubMed ID: 22460046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary fat-induced alterations in atherosclerosis are abolished by ACAT2-deficiency in ApoB100 only, LDLr-/- mice.
    Bell TA; Kelley K; Wilson MD; Sawyer JK; Rudel LL
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1396-402. PubMed ID: 17431188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of sterol O-acyltransferase 2 (SOAT2) function in mice deficient in lysosomal acid lipase (LAL) dramatically reduces esterified cholesterol sequestration in the small intestine and liver.
    Lopez AM; Posey KS; Turley SD
    Biochem Biophys Res Commun; 2014 Nov; 454(1):162-6. PubMed ID: 25450374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coordinated alteration of hepatic gene expression in fatty acid and triglyceride synthesis in LCAT-null mice is associated with altered PUFA metabolism.
    Song H; Zhu L; Picardo CM; Maguire G; Leung V; Connelly PW; Ng DS
    Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E17-E25. PubMed ID: 16105858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute sterol o-acyltransferase 2 (SOAT2) knockdown rapidly mobilizes hepatic cholesterol for fecal excretion.
    Marshall SM; Gromovsky AD; Kelley KL; Davis MA; Wilson MD; Lee RG; Crooke RM; Graham MJ; Rudel LL; Brown JM; Temel RE
    PLoS One; 2014; 9(6):e98953. PubMed ID: 24901470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted Knockdown of Hepatic SOAT2 With Antisense Oligonucleotides Stabilizes Atherosclerotic Plaque in ApoB100-only LDLr-/- Mice.
    Melchior JT; Olson JD; Kelley KL; Wilson MD; Sawyer JK; Link KM; Rudel LL
    Arterioscler Thromb Vasc Biol; 2015 Sep; 35(9):1920-7. PubMed ID: 26229140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soat2 ties cholesterol metabolism to β-oxidation and glucose tolerance in male mice.
    Pramfalk C; Ahmed O; Pedrelli M; Minniti ME; Luquet S; Denis RG; Olin M; Härdfeldt J; Vedin LL; Steffensen KR; Rydén M; Hodson L; Eriksson M; Parini P
    J Intern Med; 2022 Aug; 292(2):296-307. PubMed ID: 34982494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic acyl-coenzyme a:cholesterol acyltransferase-2 expression is decreased in mice with hyperhomocysteinemia.
    Devlin AM; Singh R; Bottiglieri T; Innis SM; Green TJ
    J Nutr; 2010 Feb; 140(2):231-7. PubMed ID: 20018805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficiency of acyl CoA:cholesterol acyltransferase 2 prevents atherosclerosis in apolipoprotein E-deficient mice.
    Willner EL; Tow B; Buhman KK; Wilson M; Sanan DA; Rudel LL; Farese RV
    Proc Natl Acad Sci U S A; 2003 Feb; 100(3):1262-7. PubMed ID: 12538880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic depletion of Soat2 diminishes hepatic steatosis via genes regulating de novo lipogenesis and by GLUT2 protein in female mice.
    Ahmed O; Pramfalk C; Pedrelli M; Olin M; Steffensen KR; Eriksson M; Parini P
    Dig Liver Dis; 2019 Jul; 51(7):1016-1022. PubMed ID: 30630736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver-specific inhibition of acyl-coenzyme a:cholesterol acyltransferase 2 with antisense oligonucleotides limits atherosclerosis development in apolipoprotein B100-only low-density lipoprotein receptor-/- mice.
    Bell TA; Brown JM; Graham MJ; Lemonidis KM; Crooke RM; Rudel LL
    Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1814-20. PubMed ID: 16675724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Niemann-Pick C1-deficient mice lacking sterol O-acyltransferase 2 have less hepatic cholesterol entrapment and improved liver function.
    Lopez AM; Jones RD; Repa JJ; Turley SD
    Am J Physiol Gastrointest Liver Physiol; 2018 Oct; 315(4):G454-G463. PubMed ID: 29878847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Anti-atherogenic Activity of Beauveriolide Derivative BVD327, a Sterol O-Acyltransferase 2-Selective Inhibitor, in Apolipoprotein E Knockout Mice.
    Ohshiro T; Imuta S; Hijikuro I; Yagyu H; Takahashi T; Doi T; Ishibashi S; Tomoda H
    Biol Pharm Bull; 2020; 43(6):951-958. PubMed ID: 32475917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic ABCG5 and ABCG8 overexpression increases hepatobiliary sterol transport but does not alter aortic atherosclerosis in transgenic mice.
    Wu JE; Basso F; Shamburek RD; Amar MJ; Vaisman B; Szakacs G; Joyce C; Tansey T; Freeman L; Paigen BJ; Thomas F; Brewer HB; Santamarina-Fojo S
    J Biol Chem; 2004 May; 279(22):22913-25. PubMed ID: 15044450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted depletion of hepatic ACAT2-driven cholesterol esterification reveals a non-biliary route for fecal neutral sterol loss.
    Brown JM; Bell TA; Alger HM; Sawyer JK; Smith TL; Kelley K; Shah R; Wilson MD; Davis MA; Lee RG; Graham MJ; Crooke RM; Rudel LL
    J Biol Chem; 2008 Apr; 283(16):10522-34. PubMed ID: 18281279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sterol O-Acyltransferase 2-Driven Cholesterol Esterification Opposes Liver X Receptor-Stimulated Fecal Neutral Sterol Loss.
    Warrier M; Zhang J; Bura K; Kelley K; Wilson MD; Rudel LL; Brown JM
    Lipids; 2016 Feb; 51(2):151-7. PubMed ID: 26729489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABCA1 overexpression in the liver of LDLr-KO mice leads to accumulation of pro-atherogenic lipoproteins and enhanced atherosclerosis.
    Joyce CW; Wagner EM; Basso F; Amar MJ; Freeman LA; Shamburek RD; Knapper CL; Syed J; Wu J; Vaisman BL; Fruchart-Najib J; Billings EM; Paigen B; Remaley AT; Santamarina-Fojo S; Brewer HB
    J Biol Chem; 2006 Nov; 281(44):33053-65. PubMed ID: 16928680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.